These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8771064)

  • 41. Bell's palsy-induced blepharospasm relieved by passive eyelid closure and responsive to apomorphine.
    Cattaneo L; Chierici E; Pavesi G
    Clin Neurophysiol; 2005 Oct; 116(10):2348-53. PubMed ID: 16098807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of idiopathic blepharospasm with botulinum toxin A].
    Toczołowski J; Romaniuk W; Wróblewska E; Stelmasiak Z; Lewandowska-Furmanik M
    Klin Oczna; 1994 Mar; 96(3):95-6. PubMed ID: 8090009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different effects of levodopa and apomorphine on blink reflex recovery cycle in essential blepharospasm.
    Napolitano A; Bonuccelli U; Rossi B
    Eur Neurol; 1997; 38(2):119-22. PubMed ID: 9286635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of Repeated Eyelid Injections with Botulinum Toxin A on Innervation of Treated Muscles in Patients with Blepharospasm.
    Olson RM; Mokhtarzadeh A; McLoon LK; Harrison AR
    Curr Eye Res; 2019 Mar; 44(3):257-263. PubMed ID: 30380945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new variant of blepharospasm.
    Elston JS
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):369-71. PubMed ID: 1602309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Types and time course of the alterations induced in monkey blink movements by botulinum toxin.
    Porter JD; Baker RS; Stava MW; Gaddie IB; Brueckner JK
    Exp Brain Res; 1993; 96(1):77-82. PubMed ID: 8243585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia.
    Gilio F; Currà A; Lorenzano C; Modugno N; Manfredi M; Berardelli A
    Ann Neurol; 2000 Jul; 48(1):20-6. PubMed ID: 10894212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin for blepharospasm: single-fiber EMG studies.
    Sanders DB; Massey EW; Buckley EG
    Neurology; 1986 Apr; 36(4):545-7. PubMed ID: 3960330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
    Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
    J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Eyelid movements before and after botulinum therapy in patients with lid spasm.
    Manning KA; Evinger C; Sibony PA
    Ann Neurol; 1990 Nov; 28(5):653-60. PubMed ID: 2260852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced long-term potentiation-like plasticity of the trigeminal blink reflex circuit in blepharospasm.
    Quartarone A; Sant'Angelo A; Battaglia F; Bagnato S; Rizzo V; Morgante F; Rothwell JC; Siebner HR; Girlanda P
    J Neurosci; 2006 Jan; 26(2):716-21. PubMed ID: 16407569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The n10 component of the ocular vestibular-evoked myogenic potential (oVEMP) is distinct from the R1 component of the blink reflex.
    Smulders YE; Welgampola MS; Burgess AM; McGarvie LA; Halmagyi GM; Curthoys IS
    Clin Neurophysiol; 2009 Aug; 120(8):1567-76. PubMed ID: 19632152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term effect of prednisolone on functional blink recovery after transient peripheral facial motor paralysis.
    VanderWerf F; Reits D; Metselaar M; De Zeeuw CI
    Otolaryngol Head Neck Surg; 2012 Mar; 146(3):448-54. PubMed ID: 22063735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
    Farrugia ME; Kennett RP; Hilton-Jones D; Newsom-Davis J; Vincent A
    Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Change of stretch reflex threshold in spasticity: effect of botulinum toxin injections.
    Stampacchia G; Bradaschia E; Rossi B
    Arch Ital Biol; 2004 May; 142(3):265-73. PubMed ID: 15260380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Botulinum toxin type A purified neurotoxin complex for the treatment of blepharospasm: a dose-response study measuring eyelid force.
    Iwashige H; Nemeto Y; Takahashi H; Maruo T
    Jpn J Ophthalmol; 1995; 39(4):424-31. PubMed ID: 8926651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Botulinum toxin treatment of muscle cramps: a clinical and neurophysiological study.
    Bertolasi L; Priori A; Tomelleri G; Bongiovanni LG; Fincati E; Simonati A; De Grandis D; Rizzuto N
    Ann Neurol; 1997 Feb; 41(2):181-6. PubMed ID: 9029067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Use of botulinum toxin A in treatment of blepharospasm].
    Balcewicz I; Dewachter A
    Klin Oczna; 1993 Aug; 95(8):316-9. PubMed ID: 8189695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Blepharospasm: treatment with botulinum toxin].
    Barbosa ER; Silva HC; Haddad MS; Bittar MS
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):220-3. PubMed ID: 9239894
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Orbicularis oculi and orbicularis oris reflexes in blepharospasm and torticollis spasmodica during spasm-free intervals.
    Eekhof JL; Aramideh M; Speelman JD; Ongerboer de Visser BW
    Eur Neurol; 2001; 46(2):75-8. PubMed ID: 11528155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.